Observed Signal · Oct 22, 2026 · earnings · Source: SEC API · Impact: 4.2/5
10-Q Financial Filing Analysis for IBM (2026-10-22)
IBM reported strong financial results for the third quarter ended September 30, 2026, with total revenue rising 4.7% year-over-year (5.6% in constant currency) to $17.10 billion, driven primarily by an 8.2% expansion in the Software segment ($7.80 billion) and 4.2% growth in Infrastructure ($3.71 billion). Net income for the quarter reached $2.19 billion, up 25.6% from $1.74 billion in Q3 2025, supported by operational discipline, the integration of Confluent, and the absence of prior-year one-time tax reform charges. Diluted earnings per share from continuing operations grew 25.5% to $2.31 (non-GAAP operating EPS rose 11.3% to $2.95). Free cash flow generation reached $3.0 billion for the quarter and $7.79 billion year-to-date, underpinning capital returns of $1.60 billion in quarterly dividends. Operationally, IBM advanced its hybrid cloud and enterprise AI positioning through watsonx scaling and strategic acquisitions, while securing a landmark U.S. CHIPS Act agreement providing up to $1.0 billion in federal incentives for quantum wafer R&D at its Anderon subsidiary.
Demonstrates robust execution in IBM's high-margin Software and Hybrid Cloud/AI transformation following major M&A integrations (Confluent, HashiCorp), paired with long-term strategic expansion into quantum hardware backed by U.S. CHIPS Act funding.
Track IBM Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Q3 2026 revenue increased 4.7% year-over-year to $17.10 billion (gross profit of $9.71 billion), while net income expanded 25.6% to $2.19 billion ($2.30 diluted EPS).
- Software segment revenue rose 8.2% to $7.80 billion, driven by double-digit growth in Data (+19.1%) bolstered by the Confluent acquisition and Hybrid Cloud (+10.6%).
- Anderon LLC, an IBM subsidiary, entered an award agreement under the U.S. CHIPS Act providing up to $1.0 billion in incentives ($650 million at closing) for quantum wafer manufacturing R&D, alongside a $1.0 billion IBM cash commitment.
Connected Companies & Entities
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
IBM Beats Q3 Estimates as CEO Touts Super Intelligence
IBM reported better-than-expected third-quarter results, beating on both earnings and revenue. Adjusted earnings were $2.95 per share versus the $2.86 expected, and revenue came in at $17.10 billion, above the $16.82 billion consensus. Revenue grew 5% year-over-year, driven by software revenue of $7.80 billion, which grew 8% and beat expectations. The company raised its full-year free cash flow forecast to an increase of more than $1 billion. CEO Arvind Krishna highlighted client deployments of 'Super Intelligence' transforming operating models. Consulting revenue remained flat at $5.34 billion, with AI representing about 30% of consulting revenue. IBM also announced the acquisition of HRL Laboratories from Boeing and General Motors to bolster its quantum computing capabilities.
IBM Lowers 2026 Forecast After Q2 Earnings Miss
IBM reported second-quarter results on July 22, 2026 that fell short of LSEG consensus, and the company lowered its full-year 2026 revenue-growth forecast. Adjusted EPS was $2.93 versus $2.97 expected and revenue was $17.16 billion versus $17.58 billion expected. IBM said revenue grew 1% year‑over‑year and net income was $2.17 billion. Management now expects 4%–5% constant‑currency revenue growth for 2026 (down from a prior target above 5%), and reiterated plans for $1 billion in additional free cash flow. The company highlighted efforts to accelerate productivity via AI, introduced an internal AI coding tool called Bob, and signed a letter of intent related to a U.S. quantum chip foundry.
IBM Wins $1B Quantum Grant; Stock Jumps, Options Trade Shared
IBM's stock jumped more than 12.5% after the U.S. Department of Commerce signed a Letter of Intent under the CHIPS and Science Act to award over $2 billion in federal grants aimed at securing the domestic quantum computing supply chain; IBM received the maximum award of $1 billion. The article notes IBM's broader product moves — new AI inference and virtualization services on its cloud with Red Hat and an expanded partnership with Oracle to bring watsonx to Oracle Cloud Infrastructure, with watsonx Orchestrate agent offerings due in July. Author Jeff Kilburg describes an options-based trade to gain defined upside exposure while hedging risk and discloses he is long IBM and the positions he discussed.
Receive all future signals for IBM & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.